当前位置:首页 > 股票大全 > 金域医学 603882 财务分析

金域医学财务分析

整理编辑:168股票行情网www.gphq168.com    数据来源:互联网 经供参考

金域医学(603882)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入1,841,260,736.258,539,627,901.456,309,622,119.424,308,511,708.02
营业总成本1,739,097,569.97,635,230,948.345,575,699,748.493,676,616,414.73
营业利润-25,021,248.83759,762,074.2642,415,135.81336,305,005.29
利润总额-26,805,941.85740,288,544.32627,163,774.35325,929,111.95
净利润-26,419,413.39636,908,511.03566,649,689.09282,235,598.93
其他综合收益80,537.67,990,400.1815,242,181.5413,272,729.33
综合收益总额-26,338,875.79644,898,911.21581,891,870.63295,508,328.26
金域医学(603882)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计8,132,426,078.688,265,141,988.728,602,262,763.268,867,486,530.3
非流动资产合计3,469,906,558.133,502,530,459.853,560,789,685.723,363,605,901.52
资产总计11,602,332,636.8111,767,672,448.5712,163,052,448.9812,231,092,431.82
流动负债合计2,654,609,351.642,689,182,215.212,946,558,088.073,396,900,140.25
非流动负债合计566,805,009.64531,098,069.25539,735,869.34459,597,900.54
负债合计3,221,414,361.283,220,280,284.463,486,293,957.413,856,498,040.79
归属于母公司股东权益合计8,203,286,771.878,362,834,963.488,475,913,707.578,132,422,609.58
股东权益合计8,380,918,275.538,547,392,164.118,676,758,491.578,374,594,391.03
负债和股东权益合计11,602,332,636.8111,767,672,448.5712,163,052,448.9812,231,092,431.82
金域医学(603882)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计1,577,281,891.1210,012,801,543.317,070,111,543.344,799,744,693.14
经营活动现金流出小计1,715,592,710.448,781,980,923.636,562,300,401.584,446,113,886.81
经营活动产生的现金流量净额-138,310,819.321,230,820,619.68507,811,141.76353,630,806.33
投资活动现金流入小计647,570.53237,457,496.02218,532,762.44151,068.29
投资活动现金流出小计97,857,943.64871,991,928.08702,668,175.72301,830,359.51
投资活动产生的现金流量净额-97,210,373.11-634,534,432.06-484,135,413.28-301,679,291.22
筹资活动现金流入小计65,159,738.92248,022,930.71226,210,832.578,934,865
筹资活动现金流出小计174,788,077.21,310,038,495.911,138,747,204.541,078,351,627.21
筹资活动产生的现金流量净额-109,628,338.28-1,062,015,565.2-912,536,372.04-999,416,762.21
汇率变动对现金及现金等价物的影响203,344.87,386,664.4620,978,760.8224,153,801.15
现金及现金等价物净增加额-344,946,185.91-458,342,713.12-867,881,882.74-923,311,445.95
期末现金及现金等价物余额2,104,727,955.322,449,674,141.232,040,134,971.611,984,705,408.4
金域医学603882相关数据
今日股市大盘指数